All
Why the Cancer Caregiver Journey Cannot Be Overlooked When Discussing Patient Care
November 18th 2020Heather Badt, CSC’s Executive Director of the Research & Training Institute, recently shared her personal perspective as a former patient and caregiver with CURE® and expanded on how those who care for loved ones with cancer often face their own unique challenges and require specialized resources themselves
Racial and Other Disparities Persist Among Patients with Extensive-Stage Small Cell Lung Cancer
November 16th 2020Among patients with extensive-stage small cell lung cancer, several groups were found to receive chemotherapy less often compared with White patients. They included Black, older and uninsured patients as well as those with nonprivate health insurance.
Cancer May Not Suggest Poor Health Outcomes After COVID-19, Study Shows
November 16th 2020A retrospective study of patients with COVID-19 showed that those with cancer were not more likely to experience severe symptoms or death due to the virus than those without cancer. Rather, only age and obesity were associated with poor COVID-19 outcomes.
The Importance of Connecting to Peers With Cancer
November 15th 2020No matter how great the support system, care center or caregiver, it's nearly impossible for patients with cancer to fully share their experiences with those that don't understand. Which is why it's so important for patients to find peers to discuss their cancer with.
Navigating the Psychosocial Effects That Can Outlast Cancer And Its Treatment
November 15th 2020By 2040, experts predict there will be more than 26 million cancer survivors in America. Based on findings from several studies, these survivors can expect to spend large portions of their lives managing the disease’s effect on their physical and mental well-being.
FDA Grants Accelerated Approval to Keytruda-Chemotherapy Combination for TNBC
November 13th 2020The Food and Drug Administration has approved the combination of Keytruda (pembrolizumab) with chemotherapy for patients with locally recurrent unresectable or metastatic triple-negative breast cancer who have a PD-L1 expression.
When Weighing Treatment Options for Cancer, It’s Important to Get More Than One Opinion
November 13th 2020“The concept that people have sometimes is that they put doctors on a pedestal, which is fine,” Bud Green said. And they somehow think that all doctors are kind of the same, and they're all as good. And I think that they need to see that different specialties look at things from a different perspective.